Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonistsMIN AMY XIANG; CHEN, Robert H; DEMAREST, Keith T et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 12, pp 3143-3146, issn 0960-894X, 4 p.Article

The vasopressin system : Physiology and clinical strategiesTRESCHAN, Tanja A; PETERS, Jürgen.Anesthesiology (Philadelphia). 2006, Vol 105, Num 3, pp 599-612, issn 0003-3022, 14 p.Article

Central Vasopressin V1a Receptor Activation Is Independently Necessary for Both Partner Preference Formation and Expression in Socially Monogamous Male Prairie VolesDONALDSON, Zoe R; SPIEGEL, Lauren; YOUNG, Larry J et al.Behavioral neuroscience. 2010, Vol 124, Num 1, pp 159-163, issn 0735-7044, 5 p.Article

Both V_1A and V_1B vasopressin receptors deficiency result in impaired glucose toleranceNAKAMURA, Kazuaki; AOYAGI, Toshinori; HIROYAMA, Masami et al.European journal of pharmacology. 2009, Vol 613, Num 1-3, pp 182-188, issn 0014-2999, 7 p.Article

TolvaptanDUBOIS, Eline A; RISSMANN, Robert; COHEN, Adam F et al.British journal of clinical pharmacology. 2012, Vol 73, Num 1, pp 9-11, issn 0306-5251, 3 p.Article

Visualizing Microtubule-Dependent Vasopressin Type 2 Receptor Trafficking Using a New High-Affinity Fluorescent Vasopressin LigandCHEN, Sylvia; WEBBER, Matthew J; VILARDAGA, Jean-Pierre et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 10, pp 3893-3904, issn 0013-7227, 12 p.Article

V_1b receptors : New probes for therapyARBAN, Roberto.Endocrinology (Philadelphia). 2007, Vol 148, Num 9, pp 4133-4135, issn 0013-7227, 3 p.Article

Vascular Effects of RWJ-676070, a Selective Combined V_1a/V₂ Vasopressin Receptor AntagonistCOLTAMAI, L; BUCHER, M; MAILLARD, M. P et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 2, pp 145-148, issn 0009-9236, 4 p.Article

Apelin and Vasopressin: Two Work Better than OneLLORENS-CORTES, Catherine; MOOS, Francoise.Journal of neuroendocrinology. 2012, Vol 24, Num 7, pp 1085-1086, issn 0953-8194, 2 p.Article

The role of vasopressin in the genetic and neural regulation of monogamyLIM, M. M; HAMMOCK, E. A. D; YOUNG, L. J et al.Journal of neuroendocrinology. 2004, Vol 16, Num 4, pp 325-332, issn 0953-8194, 8 p.Conference Paper

AVP receptors of mouse Leydig cells are regulated by LH and E₂ and influenced by experimental cryptorchidismTAHRI-JOUTEI, A; POINTIS, G.FEBS letters. 1989, Vol 254, Num 1-2, pp 189-193, issn 0014-5793, 5 p.Article

A case of refractory intraoperative hypotension treated with vasopressin infusionWHEELER, Adam D; TURCHIANO, John; TOBIAS, Joseph D et al.Journal of clinical anesthesia. 2008, Vol 20, Num 2, pp 139-142, issn 0952-8180, 4 p.Article

The hormone domain of the vasopressin prohormone is required for the correct prohormone trafficking through the secretory pathwayDE BREE, F. M; VAN DER KLEIJ, A. A. M; NIJENHUIS, M et al.Journal of neuroendocrinology. 2003, Vol 15, Num 12, pp 1156-1163, issn 0953-8194, 8 p.Article

Vasopressin in catecholamine-refractory shock in childrenMEYER, S; GORTNER, L; MCGUIRE, W et al.Anaesthesia. 2008, Vol 63, Num 3, pp 228-234, issn 0003-2409, 7 p.Article

Selectivity of d[Cha⁴]AVP and SSR149415 at human vasopressin and oxytocin receptors : evidence that SSR149415 is a mixed vasopressin V_1b/oxytocin receptor antagonistGRIFFANTE, Cristiana; GREEN, Andrew; CURCURUTO, Ornella et al.British journal of pharmacology. 2005, Vol 146, Num 5, pp 744-751, issn 0007-1188, 8 p.Article

Pharmacological characterization of RWJ-676070, a dual vasopressin V_1A/V₂ receptor antagonistGUNNET, Joseph W; WINES, Pamela; MARYANOFF, Bruce E et al.European journal of pharmacology. 2008, Vol 590, Num 1-3, pp 333-342, issn 0014-2999, 10 p.Article

Peritubular AVP regulates bicarbonate reabsorption in cortical distal tubule via V₁ and V₂ receptorsMUSA-AZIZ, Raif; MORAIS BARRETO-CHAVES, Maria Luisa; DE MELLO-AIRES, Margarida et al.American journal of physiology. Renal physiology. 2002, Vol 51, Num 2, pp F256-F264, issn 1931-857XArticle

Water in health and disease : new aspects of disturbances in water metabolismPETERS, H. P. E; ROBBEN, J. H; DEEN, P. M. T et al.Netherlands journal of medicine. 2007, Vol 65, Num 9, issn 0300-2977, 325-332 [8 p.]Article

Moderate-dose Vasopressin Therapy May Impair Gastric Mucosal Perfusion in Severe Sepsis: A Pilot StudyKLINZING, Stefan; SIMON, Mark; REINHART, Konrad et al.Anesthesiology (Philadelphia). 2011, Vol 114, Num 6, pp 1396-1402, issn 0003-3022, 7 p.Article

Terlipressin: An Asset for Hepatologists!SARIN, S. K; SHARMA, Praveen.Hepatology (Baltimore, Md.). 2011, Vol 54, Num 2, pp 724-728, issn 0270-9139, 5 p.Article

The Pivotal Role of Vasopressin in Refractory Anaphylactic ShockSCHUMMER, Claudia; WIRSING, Melanie; SCHUMMER, Wolfram et al.Anesthesia and analgesia. 2008, Vol 107, Num 2, pp 620-624, issn 0003-2999, 5 p.Article

Catecholamines and vasopressin during critical illnessBASSI, Gabriele; RADERMACHER, Peter; CALZIA, Enrico et al.Endocrinology and metabolism clinics of North America. 2006, Vol 35, Num 4, issn 0889-8529, x, 839-857 [20 p.]Article

Anaphylactic shock: Is vasopressin the drug of choice?SCHUMMER, Wolfram; SCHUMMER, Claudia; WIPPERMANN, Jens et al.Anesthesiology (Philadelphia). 2004, Vol 101, Num 4, pp 1025-1027, issn 0003-3022, 3 p.Article

Does arginine vasopressin influence the coagulation system in advanced vasodilator shock with severe multiorgan dysfunction syndrome?DÜNSER, Martin W; FRIES, Dietmar R; SCHOBERSBERGER, Wolfgang et al.Anesthesia and analgesia. 2004, Vol 99, Num 1, pp 201-206, issn 0003-2999, 6 p.Article

Vasopressin and terlipressin: pharmacology and its clinical relevanceKAM, P. C. A; WILLIAMS, S; YOONG, F. F. Y et al.Anaesthesia. 2004, Vol 59, Num 10, pp 993-1001, issn 0003-2409, 9 p.Article